Skip to main content
. 2018 Oct 1;217(10):3593–3607. doi: 10.1083/jcb.201804111

Figure 7.

Figure 7.

Vps13 adaptors compete to recruit Vps13 to different membranes. (A) Suppression of the mdm10Δ mitochondrial morphology defect by moderately overexpressed Mcp1 (driven by the ADH1 promoter; ↑) is partially blocked by strong overexpression of Spo71 (driven by the TEF1 promoter; ↑↑↑) and completely blocked by strong overexpression of Ypt35 (driven by the GPD1 promoter; ↑↑↑). (B) High levels of Spo71-RFP or Ypt35-RFP block the Mcp1-dependent mitochondrial targeting of Vps13^GFP, which is instead relocalized to the plasma membrane or to endosomes, respectively. DAPI (blue) marks mitochondria. Arrowheads indicate Vps13^GFP colocalization with RFP (red), mitochondria (blue), or neither (white). (C) Vps13^GFP recruitment to puncta by YPT35 (ADH1pr; ↑) is reduced by highly expressed (TEF1pr; ↑↑↑) soluble RFP chimeras with the PxP motif–containing regions of Ypt35, Mcp1, or Spo71. (D) Quantitation of Ypt35-induced Vps13^GFP puncta in RFP-expressing cells shows a significant PxP-dependent reduction of puncta when the soluble chimeras are expressed. Unpaired one-way ANOVA: n = 5, ≥890 cells/strain/replicate; P < 0.0001 overall; Holm-Sidak's multiple comparisons test, ****, P < 0.0001. (E) Vps13^GFP recruitment to puncta by moderately overexpressed MCP1 (ADH1pr; ↑) is similarly reduced by strong overexpression (TEF1pr; ↑↑↑) of soluble RFP chimeras with the PxP motif–containing regions of Ypt35, Mcp1, or Spo71. (F) Quantitation of the Mcp1-induced Vps13^GFP puncta in RFP-expressing cells shows a significant PxP-dependent reduction of puncta when the soluble chimeras are expressed. Unpaired one-way ANOVA: n = 5, ≥719 cells/strain/replicate; P < 0.0001 overall; Holm-Sidak's multiple comparisons test, ****, P < 0.0001. Error bars indicate SEM. Bars, 2 µm.